ArticleJournal of medicinal chemistry2014

Structural modifications of neuroprotective anti-Parkinsonian (-)-N6-(2-(4-(biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): an effort toward the improvement of in vivo efficacy of the parent molecule.

Gyan Modi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.